Proteomics Sandia's Biotech Initiative Going Strong, with Proteomics Niche | GenomeWeb

Sandia National Laboratories’ recent announcement of its new biotech initiative was more self-affirmation than news. But it does prove that a little advance planning can go a long way. The initiative, a strategy for rounding up Sandia’s scattered biology efforts and coordinating them, started in April of 1999 at “a half-day meeting of the senior management,” according to Len Napolitano, acting director in Sandia’s biosystems research department.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.